Iron Supplementation for Children with Iron-Deficiency Anemia

Iron deficiency anemia (IDA) is the most common nutritional deficiency disorder in children worldwide, particularly affecting infants and toddlers aged 6 months to 3 years. It arises when iron stores are depleted to the point that hemoglobin synthesis is impaired, leading to microcytic, hypochromic anemia. Clinical manifestations may include pallor, fatigue, irritability, poor appetite, developmental delays, and pica—though many cases remain asymptomatic until hemoglobin levels fall significantly.

Oral iron supplementation remains the cornerstone of treatment for pediatric IDA. Ferrous salts—especially ferrous sulfate, ferrous fumarate, and ferrous gluconate—are preferred due to their high elemental iron content and proven bioavailability. The recommended therapeutic dose is 3–6 mg/kg/day of elemental iron, administered in two to three divided doses between meals to maximize absorption. Concurrent intake of vitamin C–rich foods or supplements can further enhance non-heme iron uptake, while dairy products, tea, coffee, and calcium supplements should be avoided within two hours of dosing due to their inhibitory effects on iron absorption.

Treatment duration is critical: therapy should continue for at least 3 months after hemoglobin normalization to fully replenish iron stores, as reflected by rising serum ferritin levels. Reticulocyte count typically increases within 5–7 days, and hemoglobin usually rises by 1–2 g/dL per week; failure to respond warrants reevaluation for adherence, malabsorption, ongoing blood loss, or alternative diagnoses such as thalassemia trait or chronic inflammatory anemia.

Prevention is equally vital. Exclusive breastfeeding for the first 6 months—followed by timely introduction of iron-fortified cereals and meats—is strongly advised. For formula-fed infants, iron-fortified infant formula should be used through age 12 months. High-risk groups—including premature or low-birth-weight infants—may require prophylactic iron supplementation starting at 4 weeks of age, per AAP guidelines. Regular screening with hemoglobin and ferritin testing is recommended at key developmental windows, especially at 12 months and again at 24 months in children with risk factors.